Ian Henrich received his PhD in Pharmacology from the University of Pennsylvania School of Medicine. Dr. Henrich is highly knowledgeable in oncology and immuno-oncology, with experience in small biotech consulting, commercialization and drug development. Previously, he was a postdoctoral researcher at Children’s Hospital of Philadelphia. Dr. Henrich is also Co-Founder and Vice President, Oncology at MERLIN Biotech.
